Zilretta

3 Biotechs Launching Their First Commercial Drugs in 2018
Motley Fool
Mon, 01/1/18 - 03:13 pm
biotech
drug launches
Flexion
Zilretta
osteoarthritis of the knee
La Jolla Pharmaceutical
Giapreza
shock
Portola Pharmaceuticals
Bevyxxa
venous thromboembolism
A newly approved drug could shake up how doctors treat knee pain
Motley Fool
Tue, 11/28/17 - 09:56 am
Flexion
Zilretta
osteoarthritis of the knee
After FDA nod, Flexion launches osteoarthritis injection
Drug Delivery Business News
Mon, 11/20/17 - 09:48 am
FDA
Flexion
osteoarthritis of the knee
Zilretta
drug launch
Flexion nabs FDA OK for its potential blockbuster osteoarthritis drug, triggering new buyout buzz
Endpoints
Mon, 10/9/17 - 09:34 am
Flexion
FDA
osteoarthritis
M&A
Zilretta
3 Biotech Stocks With Big News Coming
Motley Fool
Wed, 08/2/17 - 10:16 am
biotech
Flexion
Zilretta
osteoarthritis of the knee
Zogenix
ZX008
Dravet syndrome
Keryx
chronic kidney disease
Auryxia
With an FDA decision looming, Flexion touts new data spotlighting a safety edge for osteoarthritis drug
Endpoints
Mon, 06/12/17 - 09:49 am
FDA
Flexion
Zilretta
osteoarthritis
Sanofi on verge of $1B-plus deal for arthritis-focused biotech Flexion: source
Fierce Pharma
Thu, 03/23/17 - 09:58 pm
Sanofi
Flexion
M&A
osteoarthritis of the knee
Zilretta
Top Biotech Stocks With FDA Decisions in 2017
Motley Fool
Fri, 03/3/17 - 09:42 am
FDA
Flexion
Zilretta
knee pain
osteoarthritis
neratinib
Puma Biotechnology
breast cancer
Portola
betrixaban
bloodthinners
3 Drugs Heading to the FDA Soon
Motley Fool
Mon, 12/12/16 - 09:34 am
FDA
Kite Pharma
KTE-C19
Flexion
Zilretta
AG-221
Agios Pharmaceuticals
Celgene
Trial suggests Flexion’s knee injection may be safer for diabetes patients
Bizjournals.com
Tue, 11/1/16 - 10:09 am
Flexion
diabetes
Zilretta
osteoarthritis of the knee
3 Clinical-Stage Biotechs to Buy Ahead of FDA Decisions
Motley Fool
Wed, 09/21/16 - 10:59 pm
biotech
FDA
Aerie Pharma
Rhopressa
Flexion
Zilretta
Puma Biotechnology
neratinib